ArticleJournal for immunotherapy of cancer2026

Cadonilimab (mono anti-PD-1/CTLA-4 therapy) in advanced esophageal squamous cell carcinoma.

Bi-Cheng WangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.